ALMS vs AME · rev $2.1M vs P/E 30, rev $7.40B
Alumis Inc. Common Stock (ALMS) versus Ametek Inc (AME) — a side-by-side from cached financials, not a winner call.
Alumis Inc. Common Stock (ALMS) is a biotechnology company listed on US.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Latest reported ALMS revenue for 2025-09-30 was $2.1M. Net income was -$150.4M. Revenue was down 22.5% from 2025-06-30 to 2025-09-30. ALMS currently screens at market cap $311.6M.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
ALMS currently screens at market cap $311.6M. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Not investment advice. Open the ALMS and AME stock pages for the full models.
Not investment advice.